Adoptive cell therapy can be an effective treatment for some patients with advanced cancer. This report summarizes clinical trial results from the Surgery Branch, NCI, investigating tumor infiltrating lymphocytes (TIL) and gene engineered peripheral blood T cells for the therapy of patients with melanoma and other solid tumors.
Keywords: TIL, melanoma, NY-ESO-1, interleukin-2, lymphodepletion
Citation styles
APA
Dudley, M.E. (2011). Adoptive Cell Therapy for Patients with Melanoma. Journal of Cancer, 2, 360-362. https://doi.org/10.7150/jca.2.360.
ACS
Dudley, M.E. Adoptive Cell Therapy for Patients with Melanoma. J. Cancer 2011, 2, 360-362. DOI: 10.7150/jca.2.360.
NLM
Dudley ME. Adoptive Cell Therapy for Patients with Melanoma. J Cancer 2011; 2:360-362. doi:10.7150/jca.2.360. https://www.jcancer.org/v02p0360.htm
CSE
Dudley ME. 2011. Adoptive Cell Therapy for Patients with Melanoma. J Cancer. 2:360-362.